🇺🇸 Uro-Vaxom in United States

52 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Urinary Tract Infection — 10 reports (19.23%)
  2. Headache — 7 reports (13.46%)
  3. Dyspnoea — 5 reports (9.62%)
  4. Pain — 5 reports (9.62%)
  5. Vision Blurred — 5 reports (9.62%)
  6. Chest Discomfort — 4 reports (7.69%)
  7. Confusional State — 4 reports (7.69%)
  8. Dry Eye — 4 reports (7.69%)
  9. Eye Irritation — 4 reports (7.69%)
  10. Fatigue — 4 reports (7.69%)

Source database →

Uro-Vaxom in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Uro-Vaxom approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Uro-Vaxom in United States?

Swiss Paraplegic Research, Nottwil is the originator. The local marketing authorisation holder may differ — check the official source linked above.